198 related articles for article (PubMed ID: 27003114)
1. l-arginine and docetaxel synergistically enhance anti-tumor immunity by modifying the immune status of tumor-bearing mice.
Cao Y; Wang Q; Du Y; Liu F; Zhang Y; Feng Y; Jin F
Int Immunopharmacol; 2016 Jun; 35():7-14. PubMed ID: 27003114
[TBL] [Abstract][Full Text] [Related]
2. L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo.
Cao Y; Feng Y; Zhang Y; Zhu X; Jin F
BMC Cancer; 2016 Jun; 16():343. PubMed ID: 27246354
[TBL] [Abstract][Full Text] [Related]
3. The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer.
Qiu C; Yang L; Wang B; Cui L; Li C; Zhuo Y; Zhang L; Zhang S; Zhang Q; Wang X
Biomed Pharmacother; 2019 Jul; 115():108952. PubMed ID: 31078044
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
5. A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers.
Kodumudi KN; Woan K; Gilvary DL; Sahakian E; Wei S; Djeu JY
Clin Cancer Res; 2010 Sep; 16(18):4583-94. PubMed ID: 20702612
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin.
Zhou J; Donatelli SS; Gilvary DL; Tejera MM; Eksioglu EA; Chen X; Coppola D; Wei S; Djeu JY
Sci Rep; 2016 Jul; 6():29521. PubMed ID: 27405665
[TBL] [Abstract][Full Text] [Related]
7. Combined administration of the apoptin gene and poly (I:C) induces potent anti-tumor immune response and inhibits growth of mouse mammary tumors.
Gupta SK; Tiwari AK; Gandham RK; Sahoo AP
Int Immunopharmacol; 2016 Jun; 35():163-173. PubMed ID: 27064544
[TBL] [Abstract][Full Text] [Related]
8. Effects of Shugan Jianpi Formula () on myeloid-derived suppression cells-mediated depression breast cancer mice.
Lu YT; Li J; Qi X; Pei YX; Shi WG; Lin HS
Chin J Integr Med; 2017 Jun; 23(6):453-460. PubMed ID: 27796822
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of curcumin on myeloid-derived suppressor cells is requisite for controlling lung cancer.
Liu D; You M; Xu Y; Li F; Zhang D; Li X; Hou Y
Int Immunopharmacol; 2016 Oct; 39():265-272. PubMed ID: 27497194
[TBL] [Abstract][Full Text] [Related]
10. Recombinant virus-like particles presenting IL-33 successfully modify the tumor microenvironment and facilitate antitumor immunity in a model of breast cancer.
Feng X; Liu H; Chu X; Sun P; Huang W; Liu C; Yang X; Sun W; Bai H; Ma Y
Acta Biomater; 2019 Dec; 100():316-325. PubMed ID: 31542504
[TBL] [Abstract][Full Text] [Related]
11. Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions.
Maulhardt H; Marin A; Hesseltine H; diZerega G
Med Oncol; 2021 Jul; 38(9):106. PubMed ID: 34331595
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice.
Khosravianfar N; Hadjati J; Namdar A; Boghozian R; Hafezi M; Ashourpour M; Kheshtchin N; Banitalebi M; Mirzaei R; Razavi SA
Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):47-55. PubMed ID: 29512369
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model.
Vo MC; Yang S; Jung SH; Chu TH; Lee HJ; Lakshmi TJ; Park HS; Kim HJ; Lee JJ
Front Immunol; 2018; 9():1798. PubMed ID: 30123221
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine (CQ) exerts anti-breast cancer through modulating microenvironment and inducing apoptosis.
Zhang Y; Cao Y; Sun X; Feng Y; Du Y; Liu F; Yu C; Jin F
Int Immunopharmacol; 2017 Jan; 42():100-107. PubMed ID: 27912145
[TBL] [Abstract][Full Text] [Related]
15. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
Guo Z; Wang H; Meng F; Li J; Zhang S
J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
[TBL] [Abstract][Full Text] [Related]
16. Supplementation of l-arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapy.
Satoh Y; Kotani H; Iida Y; Taniura T; Notsu Y; Harada M
Cancer Sci; 2020 Jul; 111(7):2248-2258. PubMed ID: 32426941
[TBL] [Abstract][Full Text] [Related]
17. Anti-MUC1 monoclonal antibody (C595) and docetaxel markedly reduce tumor burden and ascites, and prolong survival in an in vivo ovarian cancer model.
Wang L; Chen H; Pourgholami MH; Beretov J; Hao J; Chao H; Perkins AC; Kearsley JH; Li Y
PLoS One; 2011; 6(9):e24405. PubMed ID: 21931707
[TBL] [Abstract][Full Text] [Related]
18. Synergistic enhancement of cancer therapy using a combination of ceramide and docetaxel.
Feng LX; Li M; Liu YJ; Yang SM; Zhang N
Int J Mol Sci; 2014 Mar; 15(3):4201-20. PubMed ID: 24619193
[TBL] [Abstract][Full Text] [Related]
19. Baccatin III, a precursor for the semisynthesis of paclitaxel, inhibits the accumulation and suppressive activity of myeloid-derived suppressor cells in tumor-bearing mice.
Lee YH; Lee YR; Park CS; Im SA; Song S; Hong JT; Whang BY; Kim K; Lee CK
Int Immunopharmacol; 2014 Aug; 21(2):487-93. PubMed ID: 24957690
[TBL] [Abstract][Full Text] [Related]
20. Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment.
van Hooren L; Georganaki M; Huang H; Mangsbo SM; Dimberg A
Oncotarget; 2016 Jul; 7(31):50277-50289. PubMed ID: 27385210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]